Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:20 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 385–408 of 589 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: SIGNAL Clear all

Conditions: Myocardial Perfusion Imaging, Magnetic Resonance Imaging
Interventions: Gadavist 15Ml Solution for Injection; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Parkinson Disease, Essential Tremor, Dystonia
Interventions: electrophysiological data collection; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 85 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Decision Making, Computer Aided Diagnosis
Interventions: Simulated Second Reader AI, Target Prevalence; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Consciousness, Level Altered
Interventions: Low-intensity focused ultrasound pulsation (LIFUP), Functional Magnetic Resonance Imaging (fMRI), Magnetic Resonance Spectroscopy, Multi-modal glymphatic function MRI; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 40 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Coronary Artery Disease
Interventions: Invasive Cardiac Catheterization (ICA), Coronary Computed Tomographic Angiogram (CCTA), Dynamic Cardiac Positron Emission Tomography (dPET); Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 3
States / cities: Atlanta, Georgia • Roslyn, New York

Conditions: Neuromuscular Blockade, Intraoperative Monitoring, Skin Preparation, Electromyography
Interventions: Gentle Skin Abrasion Before EMG-Based Neuromuscular Blockade Monitoring; Procedure
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: IgG4 Related Disease, IgG4-RD
Interventions: elotuzumab, placebo for elotuzumab, methylprednisolone, diphenhydramine, acetaminophen, famotidine, prednisone; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Atlanta, Georgia • Boston, Massachusetts • Rochester, Minnesota

Conditions: Solid Tumor, Advanced Solid Tumor, Metastatic Solid Tumor
Interventions: BSI-082, Trastuzumab deruxtecan; Drug · Other
Lead sponsor: Lei Zheng; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Migraine
Interventions: Stimulation of the Occipital Nerves; Device
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 8 Years to 65 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 4
States / cities: Newington, New Hampshire • New York, New York • Cincinnati, Ohio + 1 more

Conditions: Rotator Cuff Tear
Interventions: Ivivi Torino II, Inactive Sham device; Device
Lead sponsor: Amp Orthopedics, Inc.; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 3
States / cities: New Orleans, Louisiana • Jackson, Mississippi • Taos, New Mexico

Conditions: Healthy Aging
Interventions: Roll Tilt Training, Translation Training, Both Tilt and Translation Training, Placebo Control; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 65 Years to 89 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Acute Disease, Disease Progression, Critical Illness, Biomarkers, Aging, Digital Health, Wearable Electronic Devices, Remote Patient Monitoring
Interventions: Multimodal Digital Biomarker Monitoring; Other
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2039
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip, Avascular Necrosis, Rheumatoid Arthritis
Interventions: POPOP (preoperative patient optimization program), SOC (standard of care); Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 80 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Speech Sound Disorder
Interventions: Visual-Acoustic Biofeedback Treatment, No Treatment; Behavioral · Other
Lead sponsor: Montclair State University; Other
Eligibility: 9 Years to 15 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Upper Montclair, New Jersey

Conditions: Obesity
Interventions: Oral glucose tolerance test, Cognitive testing, Magnetic resonance imaging; Procedure · Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Non-small Cell Lung Cancer (NSCLC)
Interventions: Calypso Beacon Implantation; Device
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 4
States / cities: Middletown, New Jersey • Commack, New York • Harrison, New York + 1 more

Conditions: Long COVID, Chronic Fatigue Syndrome
Interventions: Transcutaneous Non-Invasive Vagus Nerve Stimulation; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: Up to 70 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Malnutrition, Child, Wasting Disease, Stunting, Malnutrition, Malnutrition, Mother
Interventions: Cash only, Cash + Social Behavior Change Communication, Cash + top-up cash; Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 6 Months and older
Enrollment: 3,384 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Acute Respiratory Illness, Viral Respiratory Infection
Interventions: MBP® Breath Analyzer; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 7 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Addiction Nicotine
Interventions: Neurofeedback (from fMRI and/or EEG); Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Multiple Myeloma
Interventions: Dexamethasone, Pomalidomide, Elotuzumab, Nivolumab; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: PARKINSON DISEASE (Disorder)
Interventions: aDBS-Extended (Medtronic Percept™), aDBS-Standard (Medtronic Percept™), Continuous DBS (cDBS) - Active Control (Medtronic Percept™); Device
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Davis, California

Conditions: Advanced Melanoma, Unresectable Melanoma
Interventions: Nivolumab, Axitinib; Drug
Lead sponsor: Yana Najjar; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pediatric Obesity
Interventions: Pro2 - 75% of participant's MIP, Pro2 - 15% of participant's MIP; Device
Lead sponsor: Duke University; Other
Eligibility: 8 Years to 17 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Dotarem Evaluation for Myocardial Perfusion CMR

Cortical-Basal Ganglia Speech Networks

Project 3 Example: Human-AI Collaboration Tester (HAICT) Exp. 7

Investigating Near-Threshold Perception During Ultrasonic Deep Brain Stimulation

Quantification of Myocardial Blood Flow Using Dynamic PET/CTA Fused Imagery

Gentle Skin Abrasion and EMG-Based Neuromuscular Blockade Monitoring

Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)

Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors

Occipital Nerve Stimulation in the Treatment of Migraine

Effectiveness of the Ivivi Torino II, Pulsed Radio Frequency Device, on Narcotic Use, Pain and Quality of Life Following Shoulder Arthroscopic Rotator Cuff Repair.

Effect of Vestibular Perceptual Learning on Vestibular Thresholds and Balance

Multimodal Digital Biomarker Prediction of Acute Clinical Deterioration

Impact of a POPOP on Preoperative Health, Eligibility, and Clinical & Patient-Reported Outcomes in TJA

Visual Acoustic Biofeedback for RSE Via Telepractice

Cognition and Magnetic Resonance Imaging of Brain Inflammation in Obesity

Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer

Vagus Nerve Stimulation as Treatment for Long Covid

Cash Plus Interventions for Prevention of Acute Malnutrition in Children Under 5 and Their Mothers in Somalia

Vocxi Breath Analyzer Study in Pediatric Respiratory Infection

Self-activation in Individuals With and Without Nicotine Dependence

An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma

Optimizing Adaptive DBS for Parkinson's Disease

Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma

Inspiratory Muscle Rehabilitation in Children With Obesity